Nanoscope Therapeutics Wins ‘Top Retina Company’ Award at 2021 Eyecelerator Conference for Its Optogenetics Gene Therapy to Restore Vision in People Blinded by Retinal Diseases
- Friday, December 3, 2021, 7:12
- PR Newswire
- Add a comment
BEDFORD, Texas, Dec. 3, 2021 /PRNewswire/ — Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic gene therapies for treatment of retinal degenerative diseases, was awarded as the Top Retina Company at the Eyecelerator conference at the 2021 meeting…
About the Author
admin has written 20652 stories on this site.